JIAXUN ZOU: Open Payments
NPI 1659064194 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,123 in 85 payments from 10 companies in 2025. Trend: 2023 $861 · 2024 $1,323 · 2025 $2,123
Food & beverage: $2,123
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $607 |
| PFIZER INC. | 11 | $489 |
| Arcutis Biotherapeutics, Inc. | 38 | $464 |
| LEO Pharma Inc. | 8 | $260 |
| ABBVIE INC. | 4 | $174 |
| GENZYME CORPORATION | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Organon LLC | 1 | $22 |
| LNHC, Inc | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: TREMFYA, Zoryve, ANZUPGO, CIBINQO, SKYRIZI, LITFULO, DUPIXENT, Rhapsido.
Industry payments across NY — which companies pay providers there.
